nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP2E1—Pilocarpine—glaucoma	0.0893	0.139	CbGbCtD
Ondansetron—CYP2E1—Methazolamide—glaucoma	0.0603	0.0941	CbGbCtD
Ondansetron—CYP2D6—Carteolol—glaucoma	0.0561	0.0876	CbGbCtD
Ondansetron—CYP1A2—Betaxolol—glaucoma	0.046	0.0718	CbGbCtD
Ondansetron—CYP2D6—Betaxolol—glaucoma	0.0379	0.0592	CbGbCtD
Ondansetron—CYP2C9—Diclofenamide—glaucoma	0.0365	0.057	CbGbCtD
Ondansetron—CYP2C9—Dorzolamide—glaucoma	0.0352	0.055	CbGbCtD
Ondansetron—CYP3A5—Clonidine—glaucoma	0.0339	0.0529	CbGbCtD
Ondansetron—CYP2C9—Methazolamide—glaucoma	0.0314	0.049	CbGbCtD
Ondansetron—CYP2D6—Methazolamide—glaucoma	0.0287	0.0448	CbGbCtD
Ondansetron—CYP3A4—Pilocarpine—glaucoma	0.027	0.0422	CbGbCtD
Ondansetron—CYP1A2—Clonidine—glaucoma	0.0252	0.0394	CbGbCtD
Ondansetron—CYP2D6—Timolol—glaucoma	0.0244	0.0381	CbGbCtD
Ondansetron—CYP3A4—Brinzolamide—glaucoma	0.0212	0.0331	CbGbCtD
Ondansetron—CYP2D6—Clonidine—glaucoma	0.0208	0.0324	CbGbCtD
Ondansetron—CYP3A4—Dorzolamide—glaucoma	0.0205	0.032	CbGbCtD
Ondansetron—CYP3A4—Methazolamide—glaucoma	0.0183	0.0285	CbGbCtD
Ondansetron—CYP3A4—Acetazolamide—glaucoma	0.0146	0.0228	CbGbCtD
Ondansetron—CYP3A4—Clonidine—glaucoma	0.0132	0.0206	CbGbCtD
Ondansetron—Bradycardia—Betaxolol—glaucoma	0.000343	0.00114	CcSEcCtD
Ondansetron—Fatigue—Acetazolamide—glaucoma	0.000343	0.00114	CcSEcCtD
Ondansetron—Paraesthesia—Brimonidine—glaucoma	0.000343	0.00114	CcSEcCtD
Ondansetron—Hypotension—Dorzolamide—glaucoma	0.00034	0.00113	CcSEcCtD
Ondansetron—Dyspnoea—Brimonidine—glaucoma	0.00034	0.00113	CcSEcCtD
Ondansetron—Somnolence—Brimonidine—glaucoma	0.000339	0.00112	CcSEcCtD
Ondansetron—Hypotension—Travoprost—glaucoma	0.000339	0.00112	CcSEcCtD
Ondansetron—Shock—Pilocarpine—glaucoma	0.000339	0.00112	CcSEcCtD
Ondansetron—Bronchospasm—Timolol—glaucoma	0.000338	0.00112	CcSEcCtD
Ondansetron—Erythema—Clonidine—glaucoma	0.000337	0.00112	CcSEcCtD
Ondansetron—Tachycardia—Pilocarpine—glaucoma	0.000336	0.00111	CcSEcCtD
Ondansetron—Angina pectoris—Timolol—glaucoma	0.000335	0.00111	CcSEcCtD
Ondansetron—Hypotension—Brinzolamide—glaucoma	0.000335	0.00111	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Brimonidine—glaucoma	0.000329	0.00109	CcSEcCtD
Ondansetron—Fatigue—Brimonidine—glaucoma	0.000329	0.00109	CcSEcCtD
Ondansetron—Feeling abnormal—Acetazolamide—glaucoma	0.000328	0.00109	CcSEcCtD
Ondansetron—Hypersensitivity—Apraclonidine—glaucoma	0.000327	0.00109	CcSEcCtD
Ondansetron—Paraesthesia—Dorzolamide—glaucoma	0.000327	0.00108	CcSEcCtD
Ondansetron—Pain—Brimonidine—glaucoma	0.000326	0.00108	CcSEcCtD
Ondansetron—Dyspnoea—Dorzolamide—glaucoma	0.000325	0.00108	CcSEcCtD
Ondansetron—Visual impairment—Betaxolol—glaucoma	0.000325	0.00108	CcSEcCtD
Ondansetron—Somnolence—Dorzolamide—glaucoma	0.000324	0.00107	CcSEcCtD
Ondansetron—Dyspnoea—Travoprost—glaucoma	0.000323	0.00107	CcSEcCtD
Ondansetron—Hypotension—Pilocarpine—glaucoma	0.000322	0.00107	CcSEcCtD
Ondansetron—Paraesthesia—Brinzolamide—glaucoma	0.000322	0.00107	CcSEcCtD
Ondansetron—Dysuria—Timolol—glaucoma	0.000321	0.00107	CcSEcCtD
Ondansetron—Dyspnoea—Brinzolamide—glaucoma	0.000319	0.00106	CcSEcCtD
Ondansetron—Asthenia—Apraclonidine—glaucoma	0.000319	0.00106	CcSEcCtD
Ondansetron—Somnolence—Brinzolamide—glaucoma	0.000318	0.00106	CcSEcCtD
Ondansetron—Vision blurred—Clonidine—glaucoma	0.000317	0.00105	CcSEcCtD
Ondansetron—Urticaria—Acetazolamide—glaucoma	0.000316	0.00105	CcSEcCtD
Ondansetron—Tremor—Clonidine—glaucoma	0.000316	0.00105	CcSEcCtD
Ondansetron—Eye disorder—Betaxolol—glaucoma	0.000315	0.00104	CcSEcCtD
Ondansetron—Pruritus—Apraclonidine—glaucoma	0.000314	0.00104	CcSEcCtD
Ondansetron—Body temperature increased—Acetazolamide—glaucoma	0.000314	0.00104	CcSEcCtD
Ondansetron—Fatigue—Dorzolamide—glaucoma	0.000314	0.00104	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Travoprost—glaucoma	0.000313	0.00104	CcSEcCtD
Ondansetron—Fatigue—Travoprost—glaucoma	0.000313	0.00104	CcSEcCtD
Ondansetron—Cardiac disorder—Betaxolol—glaucoma	0.000313	0.00104	CcSEcCtD
Ondansetron—Flushing—Betaxolol—glaucoma	0.000313	0.00104	CcSEcCtD
Ondansetron—Ill-defined disorder—Clonidine—glaucoma	0.000313	0.00104	CcSEcCtD
Ondansetron—Pain—Dorzolamide—glaucoma	0.000312	0.00103	CcSEcCtD
Ondansetron—Constipation—Travoprost—glaucoma	0.00031	0.00103	CcSEcCtD
Ondansetron—Pain—Travoprost—glaucoma	0.00031	0.00103	CcSEcCtD
Ondansetron—Agitation—Clonidine—glaucoma	0.00031	0.00103	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000309	0.00103	CcSEcCtD
Ondansetron—Paraesthesia—Pilocarpine—glaucoma	0.000309	0.00103	CcSEcCtD
Ondansetron—Asthenia—Bimatoprost—glaucoma	0.000309	0.00103	CcSEcCtD
Ondansetron—Fatigue—Brinzolamide—glaucoma	0.000309	0.00102	CcSEcCtD
Ondansetron—Angioedema—Clonidine—glaucoma	0.000308	0.00102	CcSEcCtD
Ondansetron—Dyspnoea—Pilocarpine—glaucoma	0.000307	0.00102	CcSEcCtD
Ondansetron—Pain—Brinzolamide—glaucoma	0.000306	0.00102	CcSEcCtD
Ondansetron—Somnolence—Pilocarpine—glaucoma	0.000306	0.00101	CcSEcCtD
Ondansetron—Angiopathy—Betaxolol—glaucoma	0.000306	0.00101	CcSEcCtD
Ondansetron—Pruritus—Bimatoprost—glaucoma	0.000305	0.00101	CcSEcCtD
Ondansetron—Immune system disorder—Betaxolol—glaucoma	0.000304	0.00101	CcSEcCtD
Ondansetron—Diarrhoea—Apraclonidine—glaucoma	0.000304	0.00101	CcSEcCtD
Ondansetron—Malaise—Clonidine—glaucoma	0.000304	0.00101	CcSEcCtD
Ondansetron—Mediastinal disorder—Betaxolol—glaucoma	0.000304	0.00101	CcSEcCtD
Ondansetron—Chills—Betaxolol—glaucoma	0.000302	0.001	CcSEcCtD
Ondansetron—Syncope—Clonidine—glaucoma	0.000302	0.001	CcSEcCtD
Ondansetron—Arrhythmia—Betaxolol—glaucoma	0.000301	0.000998	CcSEcCtD
Ondansetron—Feeling abnormal—Dorzolamide—glaucoma	0.0003	0.000996	CcSEcCtD
Ondansetron—Feeling abnormal—Travoprost—glaucoma	0.000299	0.000991	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dorzolamide—glaucoma	0.000298	0.000988	CcSEcCtD
Ondansetron—Palpitations—Clonidine—glaucoma	0.000298	0.000987	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000297	0.000986	CcSEcCtD
Ondansetron—Gastrointestinal pain—Travoprost—glaucoma	0.000297	0.000984	CcSEcCtD
Ondansetron—Loss of consciousness—Clonidine—glaucoma	0.000296	0.000982	CcSEcCtD
Ondansetron—Feeling abnormal—Brinzolamide—glaucoma	0.000295	0.000979	CcSEcCtD
Ondansetron—Pain—Pilocarpine—glaucoma	0.000294	0.000976	CcSEcCtD
Ondansetron—Constipation—Pilocarpine—glaucoma	0.000294	0.000976	CcSEcCtD
Ondansetron—Cough—Clonidine—glaucoma	0.000294	0.000975	CcSEcCtD
Ondansetron—Dizziness—Apraclonidine—glaucoma	0.000294	0.000975	CcSEcCtD
Ondansetron—Erythema—Betaxolol—glaucoma	0.000293	0.000973	CcSEcCtD
Ondansetron—Urticaria—Dorzolamide—glaucoma	0.000289	0.00096	CcSEcCtD
Ondansetron—Body temperature increased—Dorzolamide—glaucoma	0.000288	0.000955	CcSEcCtD
Ondansetron—Abdominal pain—Dorzolamide—glaucoma	0.000288	0.000955	CcSEcCtD
Ondansetron—Chest pain—Clonidine—glaucoma	0.000287	0.000951	CcSEcCtD
Ondansetron—Abdominal pain—Travoprost—glaucoma	0.000287	0.000951	CcSEcCtD
Ondansetron—Anxiety—Clonidine—glaucoma	0.000286	0.000948	CcSEcCtD
Ondansetron—Asthenia—Acetazolamide—glaucoma	0.000285	0.000946	CcSEcCtD
Ondansetron—Dizziness—Bimatoprost—glaucoma	0.000285	0.000945	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000285	0.000945	CcSEcCtD
Ondansetron—Urticaria—Brinzolamide—glaucoma	0.000285	0.000944	CcSEcCtD
Ondansetron—Feeling abnormal—Pilocarpine—glaucoma	0.000284	0.000941	CcSEcCtD
Ondansetron—Discomfort—Clonidine—glaucoma	0.000283	0.00094	CcSEcCtD
Ondansetron—Vomiting—Apraclonidine—glaucoma	0.000283	0.000937	CcSEcCtD
Ondansetron—Gastrointestinal pain—Pilocarpine—glaucoma	0.000281	0.000934	CcSEcCtD
Ondansetron—Hypersensitivity—Brimonidine—glaucoma	0.000281	0.000932	CcSEcCtD
Ondansetron—Dry mouth—Clonidine—glaucoma	0.00028	0.00093	CcSEcCtD
Ondansetron—Bradycardia—Timolol—glaucoma	0.00028	0.000929	CcSEcCtD
Ondansetron—Dermatitis—Apraclonidine—glaucoma	0.00028	0.000928	CcSEcCtD
Ondansetron—Headache—Apraclonidine—glaucoma	0.000278	0.000923	CcSEcCtD
Ondansetron—Vision blurred—Betaxolol—glaucoma	0.000276	0.000917	CcSEcCtD
Ondansetron—Tremor—Betaxolol—glaucoma	0.000275	0.000911	CcSEcCtD
Ondansetron—Asthenia—Brimonidine—glaucoma	0.000274	0.000908	CcSEcCtD
Ondansetron—Abdominal pain—Pilocarpine—glaucoma	0.000272	0.000903	CcSEcCtD
Ondansetron—Body temperature increased—Pilocarpine—glaucoma	0.000272	0.000903	CcSEcCtD
Ondansetron—Ill-defined disorder—Betaxolol—glaucoma	0.000272	0.000902	CcSEcCtD
Ondansetron—Diarrhoea—Acetazolamide—glaucoma	0.000272	0.000902	CcSEcCtD
Ondansetron—Rash—Bimatoprost—glaucoma	0.000272	0.000901	CcSEcCtD
Ondansetron—Dermatitis—Bimatoprost—glaucoma	0.000271	0.0009	CcSEcCtD
Ondansetron—Shock—Clonidine—glaucoma	0.00027	0.000897	CcSEcCtD
Ondansetron—Pruritus—Brimonidine—glaucoma	0.00027	0.000895	CcSEcCtD
Ondansetron—Headache—Bimatoprost—glaucoma	0.00027	0.000895	CcSEcCtD
Ondansetron—Nervous system disorder—Clonidine—glaucoma	0.00027	0.000894	CcSEcCtD
Ondansetron—Hypersensitivity—Dorzolamide—glaucoma	0.000268	0.00089	CcSEcCtD
Ondansetron—Tachycardia—Clonidine—glaucoma	0.000268	0.00089	CcSEcCtD
Ondansetron—Hypersensitivity—Travoprost—glaucoma	0.000267	0.000886	CcSEcCtD
Ondansetron—Skin disorder—Clonidine—glaucoma	0.000267	0.000886	CcSEcCtD
Ondansetron—Visual impairment—Timolol—glaucoma	0.000265	0.00088	CcSEcCtD
Ondansetron—Malaise—Betaxolol—glaucoma	0.000264	0.000877	CcSEcCtD
Ondansetron—Hypersensitivity—Brinzolamide—glaucoma	0.000264	0.000875	CcSEcCtD
Ondansetron—Syncope—Betaxolol—glaucoma	0.000263	0.000872	CcSEcCtD
Ondansetron—Dizziness—Acetazolamide—glaucoma	0.000263	0.000872	CcSEcCtD
Ondansetron—Asthenia—Dorzolamide—glaucoma	0.000261	0.000867	CcSEcCtD
Ondansetron—Asthenia—Travoprost—glaucoma	0.00026	0.000863	CcSEcCtD
Ondansetron—Palpitations—Betaxolol—glaucoma	0.000259	0.000859	CcSEcCtD
Ondansetron—Pruritus—Dorzolamide—glaucoma	0.000258	0.000855	CcSEcCtD
Ondansetron—Loss of consciousness—Betaxolol—glaucoma	0.000258	0.000855	CcSEcCtD
Ondansetron—Eye disorder—Timolol—glaucoma	0.000257	0.000853	CcSEcCtD
Ondansetron—Asthenia—Brinzolamide—glaucoma	0.000257	0.000852	CcSEcCtD
Ondansetron—Hypotension—Clonidine—glaucoma	0.000257	0.000852	CcSEcCtD
Ondansetron—Pruritus—Travoprost—glaucoma	0.000257	0.000851	CcSEcCtD
Ondansetron—Cough—Betaxolol—glaucoma	0.000256	0.000849	CcSEcCtD
Ondansetron—Cardiac disorder—Timolol—glaucoma	0.000255	0.000847	CcSEcCtD
Ondansetron—Hypersensitivity—Pilocarpine—glaucoma	0.000254	0.000841	CcSEcCtD
Ondansetron—Pruritus—Brinzolamide—glaucoma	0.000253	0.00084	CcSEcCtD
Ondansetron—Vomiting—Acetazolamide—glaucoma	0.000253	0.000838	CcSEcCtD
Ondansetron—Dizziness—Brimonidine—glaucoma	0.000252	0.000837	CcSEcCtD
Ondansetron—Angiopathy—Timolol—glaucoma	0.00025	0.000828	CcSEcCtD
Ondansetron—Chest pain—Betaxolol—glaucoma	0.00025	0.000828	CcSEcCtD
Ondansetron—Diarrhoea—Dorzolamide—glaucoma	0.000249	0.000827	CcSEcCtD
Ondansetron—Headache—Acetazolamide—glaucoma	0.000249	0.000826	CcSEcCtD
Ondansetron—Anxiety—Betaxolol—glaucoma	0.000249	0.000825	CcSEcCtD
Ondansetron—Immune system disorder—Timolol—glaucoma	0.000249	0.000824	CcSEcCtD
Ondansetron—Diarrhoea—Travoprost—glaucoma	0.000248	0.000823	CcSEcCtD
Ondansetron—Mediastinal disorder—Timolol—glaucoma	0.000248	0.000823	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000248	0.000822	CcSEcCtD
Ondansetron—Asthenia—Pilocarpine—glaucoma	0.000247	0.000819	CcSEcCtD
Ondansetron—Paraesthesia—Clonidine—glaucoma	0.000247	0.000819	CcSEcCtD
Ondansetron—Discomfort—Betaxolol—glaucoma	0.000247	0.000818	CcSEcCtD
Ondansetron—Arrhythmia—Timolol—glaucoma	0.000246	0.000815	CcSEcCtD
Ondansetron—Dyspnoea—Clonidine—glaucoma	0.000245	0.000813	CcSEcCtD
Ondansetron—Diarrhoea—Brinzolamide—glaucoma	0.000245	0.000813	CcSEcCtD
Ondansetron—Somnolence—Clonidine—glaucoma	0.000244	0.000811	CcSEcCtD
Ondansetron—Dry mouth—Betaxolol—glaucoma	0.000244	0.00081	CcSEcCtD
Ondansetron—Pruritus—Pilocarpine—glaucoma	0.000244	0.000808	CcSEcCtD
Ondansetron—Dizziness—Dorzolamide—glaucoma	0.000241	0.000799	CcSEcCtD
Ondansetron—Rash—Brimonidine—glaucoma	0.000241	0.000798	CcSEcCtD
Ondansetron—Dermatitis—Brimonidine—glaucoma	0.00024	0.000797	CcSEcCtD
Ondansetron—Dizziness—Travoprost—glaucoma	0.00024	0.000796	CcSEcCtD
Ondansetron—Erythema—Timolol—glaucoma	0.00024	0.000795	CcSEcCtD
Ondansetron—Headache—Brimonidine—glaucoma	0.000239	0.000793	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Clonidine—glaucoma	0.000237	0.000787	CcSEcCtD
Ondansetron—Fatigue—Clonidine—glaucoma	0.000237	0.000786	CcSEcCtD
Ondansetron—Dizziness—Brinzolamide—glaucoma	0.000237	0.000786	CcSEcCtD
Ondansetron—Diarrhoea—Pilocarpine—glaucoma	0.000236	0.000781	CcSEcCtD
Ondansetron—Shock—Betaxolol—glaucoma	0.000235	0.000781	CcSEcCtD
Ondansetron—Pain—Clonidine—glaucoma	0.000235	0.00078	CcSEcCtD
Ondansetron—Constipation—Clonidine—glaucoma	0.000235	0.00078	CcSEcCtD
Ondansetron—Nervous system disorder—Betaxolol—glaucoma	0.000235	0.000778	CcSEcCtD
Ondansetron—Tachycardia—Betaxolol—glaucoma	0.000234	0.000775	CcSEcCtD
Ondansetron—Skin disorder—Betaxolol—glaucoma	0.000232	0.000771	CcSEcCtD
Ondansetron—Vomiting—Dorzolamide—glaucoma	0.000232	0.000768	CcSEcCtD
Ondansetron—Rash—Dorzolamide—glaucoma	0.00023	0.000762	CcSEcCtD
Ondansetron—Dermatitis—Dorzolamide—glaucoma	0.000229	0.000761	CcSEcCtD
Ondansetron—Rash—Travoprost—glaucoma	0.000229	0.000759	CcSEcCtD
Ondansetron—Dermatitis—Travoprost—glaucoma	0.000228	0.000758	CcSEcCtD
Ondansetron—Headache—Dorzolamide—glaucoma	0.000228	0.000757	CcSEcCtD
Ondansetron—Vomiting—Brinzolamide—glaucoma	0.000228	0.000755	CcSEcCtD
Ondansetron—Dizziness—Pilocarpine—glaucoma	0.000228	0.000755	CcSEcCtD
Ondansetron—Headache—Travoprost—glaucoma	0.000227	0.000754	CcSEcCtD
Ondansetron—Feeling abnormal—Clonidine—glaucoma	0.000227	0.000751	CcSEcCtD
Ondansetron—Rash—Brinzolamide—glaucoma	0.000226	0.000749	CcSEcCtD
Ondansetron—Vision blurred—Timolol—glaucoma	0.000226	0.000749	CcSEcCtD
Ondansetron—Dermatitis—Brinzolamide—glaucoma	0.000226	0.000748	CcSEcCtD
Ondansetron—Gastrointestinal pain—Clonidine—glaucoma	0.000225	0.000746	CcSEcCtD
Ondansetron—Headache—Brinzolamide—glaucoma	0.000224	0.000744	CcSEcCtD
Ondansetron—Hypotension—Betaxolol—glaucoma	0.000224	0.000742	CcSEcCtD
Ondansetron—Angioedema—Timolol—glaucoma	0.000219	0.000726	CcSEcCtD
Ondansetron—Vomiting—Pilocarpine—glaucoma	0.000219	0.000726	CcSEcCtD
Ondansetron—Urticaria—Clonidine—glaucoma	0.000218	0.000724	CcSEcCtD
Ondansetron—Abdominal pain—Clonidine—glaucoma	0.000217	0.000721	CcSEcCtD
Ondansetron—Body temperature increased—Clonidine—glaucoma	0.000217	0.000721	CcSEcCtD
Ondansetron—Rash—Pilocarpine—glaucoma	0.000217	0.00072	CcSEcCtD
Ondansetron—Dermatitis—Pilocarpine—glaucoma	0.000217	0.000719	CcSEcCtD
Ondansetron—Headache—Pilocarpine—glaucoma	0.000216	0.000715	CcSEcCtD
Ondansetron—Paraesthesia—Betaxolol—glaucoma	0.000215	0.000713	CcSEcCtD
Ondansetron—Syncope—Timolol—glaucoma	0.000215	0.000713	CcSEcCtD
Ondansetron—Dyspnoea—Betaxolol—glaucoma	0.000213	0.000708	CcSEcCtD
Ondansetron—Palpitations—Timolol—glaucoma	0.000212	0.000702	CcSEcCtD
Ondansetron—Loss of consciousness—Timolol—glaucoma	0.000211	0.000698	CcSEcCtD
Ondansetron—Cough—Timolol—glaucoma	0.000209	0.000693	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betaxolol—glaucoma	0.000207	0.000685	CcSEcCtD
Ondansetron—Fatigue—Betaxolol—glaucoma	0.000206	0.000684	CcSEcCtD
Ondansetron—Pain—Betaxolol—glaucoma	0.000205	0.000679	CcSEcCtD
Ondansetron—Constipation—Betaxolol—glaucoma	0.000205	0.000679	CcSEcCtD
Ondansetron—Chest pain—Timolol—glaucoma	0.000204	0.000676	CcSEcCtD
Ondansetron—Anxiety—Timolol—glaucoma	0.000203	0.000674	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000203	0.000672	CcSEcCtD
Ondansetron—Hypersensitivity—Clonidine—glaucoma	0.000203	0.000672	CcSEcCtD
Ondansetron—Discomfort—Timolol—glaucoma	0.000202	0.000668	CcSEcCtD
Ondansetron—Dry mouth—Timolol—glaucoma	0.000199	0.000662	CcSEcCtD
Ondansetron—Asthenia—Clonidine—glaucoma	0.000197	0.000654	CcSEcCtD
Ondansetron—Feeling abnormal—Betaxolol—glaucoma	0.000197	0.000654	CcSEcCtD
Ondansetron—Anaphylactic shock—Timolol—glaucoma	0.000196	0.000648	CcSEcCtD
Ondansetron—Pruritus—Clonidine—glaucoma	0.000194	0.000645	CcSEcCtD
Ondansetron—Shock—Timolol—glaucoma	0.000192	0.000638	CcSEcCtD
Ondansetron—Nervous system disorder—Timolol—glaucoma	0.000192	0.000636	CcSEcCtD
Ondansetron—Urticaria—Betaxolol—glaucoma	0.00019	0.000631	CcSEcCtD
Ondansetron—Skin disorder—Timolol—glaucoma	0.00019	0.00063	CcSEcCtD
Ondansetron—Body temperature increased—Betaxolol—glaucoma	0.000189	0.000627	CcSEcCtD
Ondansetron—Diarrhoea—Clonidine—glaucoma	0.000188	0.000624	CcSEcCtD
Ondansetron—Hypotension—Timolol—glaucoma	0.000183	0.000606	CcSEcCtD
Ondansetron—Dizziness—Clonidine—glaucoma	0.000182	0.000603	CcSEcCtD
Ondansetron—Hypersensitivity—Betaxolol—glaucoma	0.000176	0.000585	CcSEcCtD
Ondansetron—Paraesthesia—Timolol—glaucoma	0.000176	0.000582	CcSEcCtD
Ondansetron—Vomiting—Clonidine—glaucoma	0.000175	0.00058	CcSEcCtD
Ondansetron—Dyspnoea—Timolol—glaucoma	0.000174	0.000578	CcSEcCtD
Ondansetron—Somnolence—Timolol—glaucoma	0.000174	0.000576	CcSEcCtD
Ondansetron—Rash—Clonidine—glaucoma	0.000173	0.000575	CcSEcCtD
Ondansetron—Dermatitis—Clonidine—glaucoma	0.000173	0.000574	CcSEcCtD
Ondansetron—Headache—Clonidine—glaucoma	0.000172	0.000571	CcSEcCtD
Ondansetron—Asthenia—Betaxolol—glaucoma	0.000172	0.00057	CcSEcCtD
Ondansetron—Pruritus—Betaxolol—glaucoma	0.000169	0.000562	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Timolol—glaucoma	0.000169	0.00056	CcSEcCtD
Ondansetron—Fatigue—Timolol—glaucoma	0.000169	0.000559	CcSEcCtD
Ondansetron—Pain—Timolol—glaucoma	0.000167	0.000555	CcSEcCtD
Ondansetron—Diarrhoea—Betaxolol—glaucoma	0.000164	0.000543	CcSEcCtD
Ondansetron—Feeling abnormal—Timolol—glaucoma	0.000161	0.000534	CcSEcCtD
Ondansetron—Gastrointestinal pain—Timolol—glaucoma	0.00016	0.00053	CcSEcCtD
Ondansetron—Dizziness—Betaxolol—glaucoma	0.000158	0.000525	CcSEcCtD
Ondansetron—Urticaria—Timolol—glaucoma	0.000155	0.000515	CcSEcCtD
Ondansetron—Abdominal pain—Timolol—glaucoma	0.000155	0.000513	CcSEcCtD
Ondansetron—Body temperature increased—Timolol—glaucoma	0.000155	0.000513	CcSEcCtD
Ondansetron—Vomiting—Betaxolol—glaucoma	0.000152	0.000505	CcSEcCtD
Ondansetron—Rash—Betaxolol—glaucoma	0.000151	0.0005	CcSEcCtD
Ondansetron—Dermatitis—Betaxolol—glaucoma	0.000151	0.0005	CcSEcCtD
Ondansetron—Headache—Betaxolol—glaucoma	0.00015	0.000497	CcSEcCtD
Ondansetron—Hypersensitivity—Timolol—glaucoma	0.000144	0.000478	CcSEcCtD
Ondansetron—Asthenia—Timolol—glaucoma	0.00014	0.000465	CcSEcCtD
Ondansetron—Pruritus—Timolol—glaucoma	0.000138	0.000459	CcSEcCtD
Ondansetron—Diarrhoea—Timolol—glaucoma	0.000134	0.000444	CcSEcCtD
Ondansetron—Dizziness—Timolol—glaucoma	0.000129	0.000429	CcSEcCtD
Ondansetron—Vomiting—Timolol—glaucoma	0.000124	0.000412	CcSEcCtD
Ondansetron—Rash—Timolol—glaucoma	0.000123	0.000409	CcSEcCtD
Ondansetron—Dermatitis—Timolol—glaucoma	0.000123	0.000408	CcSEcCtD
Ondansetron—Headache—Timolol—glaucoma	0.000122	0.000406	CcSEcCtD
Ondansetron—HTR4—Signaling Pathways—SMO—glaucoma	6.13e-05	0.00106	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—C3—glaucoma	6.12e-05	0.00106	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—GSTT1—glaucoma	6.05e-05	0.00105	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—C3—glaucoma	5.98e-05	0.00103	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.91e-05	0.00102	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.91e-05	0.00102	CbGpPWpGaD
Ondansetron—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	5.84e-05	0.00101	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	5.83e-05	0.00101	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—CYP1B1—glaucoma	5.69e-05	0.000983	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—CYP1B1—glaucoma	5.65e-05	0.000975	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OPN4—glaucoma	5.64e-05	0.000974	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	5.64e-05	0.000974	CbGpPWpGaD
Ondansetron—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	5.62e-05	0.00097	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NTRK2—glaucoma	5.61e-05	0.000968	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.57e-05	0.000962	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—EDN1—glaucoma	5.57e-05	0.000962	CbGpPWpGaD
Ondansetron—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	5.57e-05	0.000962	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.27e-05	0.000911	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HEYL—glaucoma	5.24e-05	0.000905	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTGFR—glaucoma	5.08e-05	0.000877	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NARFL—glaucoma	5.01e-05	0.000865	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CA5A—glaucoma	5.01e-05	0.000865	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—OPN4—glaucoma	4.98e-05	0.00086	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NARFL—glaucoma	4.97e-05	0.000858	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CA5A—glaucoma	4.97e-05	0.000858	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.92e-05	0.00085	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—EDN1—glaucoma	4.91e-05	0.000849	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.87e-05	0.00084	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—C3—glaucoma	4.86e-05	0.00084	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—CYP1B1—glaucoma	4.82e-05	0.000833	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NGFR—glaucoma	4.81e-05	0.000831	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CA1—glaucoma	4.76e-05	0.000822	CbGpPWpGaD
Ondansetron—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.76e-05	0.000822	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.67e-05	0.000807	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HEYL—glaucoma	4.63e-05	0.000799	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CTSA—glaucoma	4.61e-05	0.000796	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NTRK1—glaucoma	4.57e-05	0.000789	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—GSTM1—glaucoma	4.55e-05	0.000786	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—GSTM1—glaucoma	4.51e-05	0.000779	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.51e-05	0.000778	CbGpPWpGaD
Ondansetron—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	4.49e-05	0.000775	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTGFR—glaucoma	4.48e-05	0.000774	CbGpPWpGaD
Ondansetron—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	4.45e-05	0.000769	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CA2—glaucoma	4.35e-05	0.000752	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—SMO—glaucoma	4.33e-05	0.000749	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OPN4—glaucoma	4.3e-05	0.000742	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—C3—glaucoma	4.29e-05	0.000741	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.27e-05	0.000737	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NARFL—glaucoma	4.24e-05	0.000733	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CA5A—glaucoma	4.24e-05	0.000733	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—EDN1—glaucoma	4.24e-05	0.000733	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.22e-05	0.000728	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.22e-05	0.000728	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CDKN2B—glaucoma	4.21e-05	0.000727	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—EDN1—glaucoma	4.04e-05	0.000698	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HEYL—glaucoma	3.99e-05	0.00069	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RPTOR—glaucoma	3.97e-05	0.000686	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTGFR—glaucoma	3.87e-05	0.000668	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.86e-05	0.000666	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NCK2—glaucoma	3.85e-05	0.000665	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—SMO—glaucoma	3.83e-05	0.000661	CbGpPWpGaD
Ondansetron—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.8e-05	0.000657	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.72e-05	0.000643	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NGF—glaucoma	3.71e-05	0.000641	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—C3—glaucoma	3.71e-05	0.00064	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.67e-05	0.000634	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	3.66e-05	0.000632	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—C3—glaucoma	3.53e-05	0.00061	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RPTOR—glaucoma	3.51e-05	0.000606	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CA1—glaucoma	3.45e-05	0.000595	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CA1—glaucoma	3.44e-05	0.000594	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NCK2—glaucoma	3.4e-05	0.000587	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CTSA—glaucoma	3.34e-05	0.000577	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CTSA—glaucoma	3.33e-05	0.000575	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—SMO—glaucoma	3.3e-05	0.00057	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—APOE—glaucoma	3.29e-05	0.000568	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CA5A—glaucoma	3.28e-05	0.000566	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NARFL—glaucoma	3.28e-05	0.000566	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HDAC9—glaucoma	3.27e-05	0.000565	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CAV1—glaucoma	3.26e-05	0.000562	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CA2—glaucoma	3.15e-05	0.000545	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—EDN1—glaucoma	3.15e-05	0.000543	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CA2—glaucoma	3.15e-05	0.000543	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—FN1—glaucoma	3.1e-05	0.000535	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—TXN—glaucoma	3.07e-05	0.00053	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—BAD—glaucoma	3.06e-05	0.000529	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RPTOR—glaucoma	3.03e-05	0.000523	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.98e-05	0.000514	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.94e-05	0.000507	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NCK2—glaucoma	2.93e-05	0.000506	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HDAC9—glaucoma	2.89e-05	0.000499	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—EDN1—glaucoma	2.86e-05	0.000494	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—EDN1—glaucoma	2.78e-05	0.00048	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—C3—glaucoma	2.75e-05	0.000475	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SMO—glaucoma	2.56e-05	0.000442	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—EDN1—glaucoma	2.52e-05	0.000436	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—C3—glaucoma	2.5e-05	0.000431	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HDAC9—glaucoma	2.49e-05	0.00043	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—NOS3—glaucoma	2.46e-05	0.000425	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CA1—glaucoma	2.45e-05	0.000422	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—C3—glaucoma	2.43e-05	0.000419	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CA1—glaucoma	2.43e-05	0.000419	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—EDN1—glaucoma	2.4e-05	0.000414	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GSTT1—glaucoma	2.38e-05	0.000411	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CTSA—glaucoma	2.37e-05	0.000409	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CTSA—glaucoma	2.35e-05	0.000406	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NTRK2—glaucoma	2.34e-05	0.000404	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SMO—glaucoma	2.26e-05	0.00039	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CA2—glaucoma	2.24e-05	0.000386	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—TXN—glaucoma	2.22e-05	0.000384	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CA2—glaucoma	2.22e-05	0.000383	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—TXN—glaucoma	2.22e-05	0.000383	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—C3—glaucoma	2.2e-05	0.00038	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—EDN1—glaucoma	2.18e-05	0.000376	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.17e-05	0.000374	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.17e-05	0.000374	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CDKN1B—glaucoma	2.13e-05	0.000368	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—C3—glaucoma	2.09e-05	0.000362	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CA1—glaucoma	2.07e-05	0.000358	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NTRK2—glaucoma	2.07e-05	0.000357	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGFR—glaucoma	2.01e-05	0.000347	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CTSA—glaucoma	2.01e-05	0.000347	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MMP9—glaucoma	1.98e-05	0.000341	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SMO—glaucoma	1.95e-05	0.000337	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NTRK1—glaucoma	1.91e-05	0.00033	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—C3—glaucoma	1.9e-05	0.000328	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CA2—glaucoma	1.9e-05	0.000327	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ABCA1—glaucoma	1.89e-05	0.000327	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CYP1B1—glaucoma	1.89e-05	0.000327	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.85e-05	0.00032	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.85e-05	0.00032	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NTRK2—glaucoma	1.78e-05	0.000308	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—VEGFA—glaucoma	1.77e-05	0.000306	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGFR—glaucoma	1.77e-05	0.000306	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CDKN2B—glaucoma	1.76e-05	0.000304	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTT1—glaucoma	1.72e-05	0.000297	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTT1—glaucoma	1.72e-05	0.000297	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—EDN1—glaucoma	1.69e-05	0.000292	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NTRK1—glaucoma	1.68e-05	0.000291	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CA1—glaucoma	1.6e-05	0.000276	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—TXN—glaucoma	1.58e-05	0.000272	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—TXN—glaucoma	1.56e-05	0.00027	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CDKN2B—glaucoma	1.55e-05	0.000268	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NGF—glaucoma	1.55e-05	0.000268	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CTSA—glaucoma	1.55e-05	0.000268	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGFR—glaucoma	1.53e-05	0.000264	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GSTM1—glaucoma	1.51e-05	0.000262	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—EDN1—glaucoma	1.49e-05	0.000257	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—C3—glaucoma	1.47e-05	0.000255	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CA2—glaucoma	1.46e-05	0.000253	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NTRK1—glaucoma	1.45e-05	0.000251	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.43e-05	0.000246	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.41e-05	0.000244	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APOE—glaucoma	1.37e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ABCA1—glaucoma	1.37e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP1B1—glaucoma	1.37e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP1B1—glaucoma	1.37e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ABCA1—glaucoma	1.37e-05	0.000237	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NGF—glaucoma	1.37e-05	0.000236	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CAV1—glaucoma	1.36e-05	0.000235	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TP53—glaucoma	1.34e-05	0.000231	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CDKN2B—glaucoma	1.34e-05	0.000231	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MTHFR—glaucoma	1.34e-05	0.000231	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—TXN—glaucoma	1.34e-05	0.000231	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—C3—glaucoma	1.3e-05	0.000225	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FN1—glaucoma	1.29e-05	0.000224	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—EDN1—glaucoma	1.29e-05	0.000222	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—BAD—glaucoma	1.28e-05	0.000221	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—APOE—glaucoma	1.25e-05	0.000215	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CAV1—glaucoma	1.23e-05	0.000213	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTT1—glaucoma	1.22e-05	0.000211	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.22e-05	0.00021	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTT1—glaucoma	1.21e-05	0.000209	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APOE—glaucoma	1.21e-05	0.000209	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.21e-05	0.000208	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CAV1—glaucoma	1.2e-05	0.000207	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NGF—glaucoma	1.18e-05	0.000204	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FN1—glaucoma	1.14e-05	0.000197	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—BAD—glaucoma	1.13e-05	0.000195	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—C3—glaucoma	1.12e-05	0.000194	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GSTM1—glaucoma	1.1e-05	0.000189	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GSTM1—glaucoma	1.09e-05	0.000189	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APOE—glaucoma	1.05e-05	0.000181	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CAV1—glaucoma	1.04e-05	0.000179	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTT1—glaucoma	1.04e-05	0.000179	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—TXN—glaucoma	1.03e-05	0.000178	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NOS3—glaucoma	1.03e-05	0.000178	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FN1—glaucoma	9.86e-06	0.00017	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.77e-06	0.000169	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—BAD—glaucoma	9.75e-06	0.000168	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCA1—glaucoma	9.74e-06	0.000168	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP1B1—glaucoma	9.74e-06	0.000168	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTHFR—glaucoma	9.7e-06	0.000167	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTHFR—glaucoma	9.68e-06	0.000167	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP1B1—glaucoma	9.65e-06	0.000167	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCA1—glaucoma	9.65e-06	0.000167	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—NOS3—glaucoma	9.34e-06	0.000161	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOS3—glaucoma	9.08e-06	0.000157	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—glaucoma	9.03e-06	0.000156	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—glaucoma	9.01e-06	0.000156	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CAV1—glaucoma	8.94e-06	0.000154	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CAV1—glaucoma	8.93e-06	0.000154	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CDKN1B—glaucoma	8.91e-06	0.000154	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—glaucoma	8.54e-06	0.000147	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.35e-06	0.000144	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—glaucoma	8.25e-06	0.000143	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP1B1—glaucoma	8.25e-06	0.000142	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCA1—glaucoma	8.25e-06	0.000142	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTT1—glaucoma	7.99e-06	0.000138	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CDKN1B—glaucoma	7.86e-06	0.000136	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOS3—glaucoma	7.84e-06	0.000135	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTM1—glaucoma	7.79e-06	0.000134	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTM1—glaucoma	7.72e-06	0.000133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—glaucoma	7.41e-06	0.000128	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—glaucoma	7.28e-06	0.000126	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—glaucoma	6.88e-06	0.000119	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—glaucoma	6.82e-06	0.000118	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CDKN1B—glaucoma	6.79e-06	0.000117	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NOS3—glaucoma	6.76e-06	0.000117	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NOS3—glaucoma	6.75e-06	0.000117	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTM1—glaucoma	6.6e-06	0.000114	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—glaucoma	6.54e-06	0.000113	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—glaucoma	6.41e-06	0.000111	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCA1—glaucoma	6.37e-06	0.00011	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP1B1—glaucoma	6.37e-06	0.00011	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—glaucoma	6.35e-06	0.00011	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAV1—glaucoma	6.35e-06	0.00011	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAV1—glaucoma	6.29e-06	0.000109	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—glaucoma	6.29e-06	0.000109	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—glaucoma	6.19e-06	0.000107	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—glaucoma	6.17e-06	0.000107	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—glaucoma	5.83e-06	0.000101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—glaucoma	5.64e-06	9.75e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—glaucoma	5.6e-06	9.67e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—glaucoma	5.43e-06	9.37e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAV1—glaucoma	5.38e-06	9.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTM1—glaucoma	5.09e-06	8.79e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—glaucoma	4.94e-06	8.53e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NOS3—glaucoma	4.8e-06	8.29e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NOS3—glaucoma	4.76e-06	8.22e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—glaucoma	4.5e-06	7.77e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—glaucoma	4.39e-06	7.58e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—glaucoma	4.35e-06	7.51e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—glaucoma	4.27e-06	7.37e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—glaucoma	4.19e-06	7.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAV1—glaucoma	4.15e-06	7.17e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NOS3—glaucoma	4.07e-06	7.02e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—glaucoma	3.72e-06	6.42e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NOS3—glaucoma	3.14e-06	5.42e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—glaucoma	2.87e-06	4.96e-05	CbGpPWpGaD
